Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07617909 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

L-Citrulline Versus Tamsulosin for Medical Expulsive Therapy of Distal Ureteral Stones

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study will compare L-citrulline and tamsulosin as medical expulsive therapy for adults with single distal ureteral stones. Eligible participants with a single distal ureteral stone measuring 5 to 10 mm will be randomly assigned to receive either oral L-citrulline 750 mg twice daily or oral tamsulosin 0.4 mg once daily. Treatment will continue until documented stone passage or completion of 4 weeks of therapy, whichever occurs first. Participants will be followed weekly for up to 4 weeks. The main outcome is stone expulsion within 4 weeks. The study will also assess time to stone expulsion, pain episodes, analgesic use, need for additional intervention, and adverse events.
Trial Details
NCT Number NCT07617909
Lead Sponsor Beni-Suef University
Conditions
(from sponsor)		 Distal Ureteral Stone, Urolithiasis, Ureteral Calculi
Related terms Ureteral Calculi, Urolithiasis
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov